Unique ID issued by UMIN | UMIN000018885 |
---|---|
Receipt number | R000021847 |
Scientific Title | Effiacy of L-carnitine for NSAID-induced small-intestinal injuries in healthy volunteer subjects: a prospective, randomised, cross-over study |
Date of disclosure of the study information | 2015/09/03 |
Last modified on | 2020/11/12 08:33:20 |
Effiacy of L-carnitine for NSAID-induced small-intestinal injuries in healthy volunteer subjects: a prospective, randomised, cross-over study
Efficacy of L-carnitine for NSAID-induced small-intestinal injuries: intervention study
Effiacy of L-carnitine for NSAID-induced small-intestinal injuries in healthy volunteer subjects: a prospective, randomised, cross-over study
Efficacy of L-carnitine for NSAID-induced small-intestinal injuries: intervention study
Japan |
NSAIDs-induced small-intestinal mucosal injuries
Gastroenterology |
Others
NO
To investigate the efficacy of L-carnitine for preventing NSAIDs-induced small-intestinal mucosal injuries
Safety,Efficacy
Comparing the severity of small-intestinal mucosal injuries in video-capsule endoscopy immediately after intervention between users of L-carnitine and non-users
Comparing the levels of oxidative-stress marker and cytokines in the serum, and the composition of intestinal bacterial flora immediately after intervention between users of L-carnitine and non-users
Interventional
Cross-over
Randomized
Individual
Open -but assessor(s) are blinded
No treatment
2
Treatment
Medicine |
Regimens are as follows;
Intervention A: indomethacin 25mg three times a day plus omeplazole 20mg once a day for seven days
Intervention B:indomethacin 25mg three times a day plus omeplazole 20mg once a dayplus L-carnitine 1000mg three times a day for seven days
Intervention 1 is as follows:
Intervention A, wash out for 4 weeks, Intervention B, and watching for 4 weeks
Intervention 2 is as follows:
Intervention B, wash out for 4 weeks, Intervention A, and watching for 4 weeks
20 | years-old | <= |
Not applicable |
Male and Female
1. healthy volunteers who have no comorbidities
2. all subjects are written informed consent
1. subjects who are taking gastric acid-inhibitory drugs (H2-blocker or PPI)
2. subjects who have been already takeing NSAID
3. subjects who have contraindications for using NSAID (gastroduodenal ulcer, bronchial asthma including aspirin asthma, severe blood diseases/hapatic injuries/renal injuries/heart failure/hypertention/pancreatitis, pregnancy and lactation, triamterene users
4. past history of abdominal surgery or ileus
10
1st name | |
Middle name | |
Last name | Hiroyuki Okada |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of Gastroenterology and Hepatology
2-5-1 Shikata-cho, Kita-ku, Okayama
086-235-7219
hiro@md.okayama-u.ac.jp
1st name | |
Middle name | |
Last name | Yoshiyasu Kono |
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of Gastroenterology and Hepatology
2-5-1 Shikata-cho, Kita-ku, Okayama
086-235-7219
hxnwq178@yahoo.co.jp
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Other
NO
2015 | Year | 09 | Month | 03 | Day |
Unpublished
Completed
2015 | Year | 08 | Month | 18 | Day |
2015 | Year | 08 | Month | 18 | Day |
2015 | Year | 09 | Month | 03 | Day |
2016 | Year | 09 | Month | 01 | Day |
2015 | Year | 09 | Month | 02 | Day |
2020 | Year | 11 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021847
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |